期刊文献+

BMP2/7异源二聚体调控CIZ的表达与自身活性的关系 被引量:6

Relationship Between the Bioactivity of BMP2/7 Heterodimers and Its Regulation of CIZ Expression
在线阅读 下载PDF
导出
摘要 BMP2/7异源二聚体的活性显著高于BMP2同源二聚体,但其机制并不清楚。采用哺乳动物细胞表达的BMP2/7异源二聚体处理成骨细胞MC3T3-E1,细胞化学染色发现BMP2/7的活性显著高于BMP2,报告载体p3GC2-LUX检测发现BMP2/7能够明显上调BMP/Smad通路的活性(P<0.05)。但在成骨细胞中过表达CIZ(casinteracting zinc finger protein),能够显著抑制BMP2/7上调ALP与Osteocalcin的作用,并阻断BMP2/7对BMP/Smad通路的激活。同时发现BMP蛋白能够上调CIZ的表达,但BMP2/7的作用明显低于BMP2同源二聚体。可以认为BMP2/7能够诱导CIZ的表达,但由于作用较弱,所以对自身活性的反馈抑制作用也较弱,这可能是BMP2/7有着较强生物活性的关键所在。 BMP2/7 heterodimer has stronger bioactivity than BMP2 homodimer, but the mechanism remains to be unclear. Treating the osteoblast MC3T3-E1 cells with BMP proteins, results of Alkalin phosphatase staining, Alizarin red staining, as well as p3GC2-LUX luciferase assay demonstrated that BMP2/7 heterodimers significantly promoted osteogenic differentiation to a higher extent than BMP2 homodimers. Overexpression of CIZ in MC3T3-E1 significantly inhibited the promotion of ALP and Osteocalcin expression by BMP2/7, and blocked activation of BMP/Smad. BMP protein may induce the expression of CIZ, but effects of BMP2/7 heterodimer is weaker than BMP2 homodimer. It suggests that the effects of BMP2/7 on CIZ expression is related to its bioactivity.
出处 《中国生物工程杂志》 CAS CSCD 北大核心 2007年第9期14-18,共5页 China Biotechnology
基金 广州市科技计划资助项目(2006Z1-E0031 2006Z3-E0791)
关键词 骨形态发生蛋白 异源二聚体 成骨细胞 分化 CIZ蛋白 Bone morphogenetic protein Heterodimer Osteoblast Differentiation CIZ protein
作者简介 通讯作者,电子信箱:sunfenyong@263.net
  • 相关文献

参考文献11

  • 1Kofron M D,Li X,Laurencin C T.Protein-and gene-based tissue engineering in bone repair.Current Opinion in Biotechnology,2004,15:399-405.
  • 2Israel D I,Nove J,Kerns K M,et al.Heterodimeric bone morphogenetic proteins show enhanced activity in vitro and in vivo.Growth Factors,1996,13:291-300.
  • 3Hazama M,Aono A,Ueno N,et al.Efficient expression of a heterodimer of bone morphogenetic protein subunits using a baculovirus expression system.Biochem Biophys Res Commun,1995,209:859-866.
  • 4Aono A,Hazama M,Notoya K,et al.Potent ectopic boneinducing activity of bone morphogenetic protein-4/7 heterodimer.Biochem Biophys Res Commun,1995,210:670-677.
  • 5Shen Z L,Nakamoto T,Tsuji K,et al.Negative regulation of bone morphogenetic protein/smad signaling by Cas-interacting zinc finger protein in Osteoblasts.J Bio Chem,2002,277 (33):29840-29846.
  • 6Kusanagi K,Inoue H,Ishidou Y,et al.Characterization of a bone morphogenetic proteinresponsive Smad-binding element.Mol Biol Cell,2000,11:555-565.
  • 7Derynck R,Zhang Y E.Smad-dependent and smad-independent pathways in TGF-β family signaling.Nature,2003,425 (9):577-584.
  • 8Massague J.How cells read TGF-b signals.Nature Rev Mol Cell Biol,2000,1:169-178.
  • 9Itoh S,Itoh F,Goumans M J.Signaling of transforming growth factor-b family members through Smad proteins.Eur J Biochem,2000,267:6954-6967.
  • 10Moustakas A,Souchelnytskyi S,Heldin C H.Smad regulation in TGF-b signal transduction.J Cell Sci,2001,114:4359-4369.

同被引文献65

  • 1林在俊,朱振安,孟凡琳,汤亭亭,楼觉人,戴尅戎.透明质酸对BMP-2转染的羊BMSCs增殖、分化的影响[J].临床骨科杂志,2007,10(4):344-347. 被引量:2
  • 2杨淑野,查振刚.转基因骨髓间充质干细胞在软骨组织工程中的研究与应用[J].临床骨科杂志,2007,10(4):362-365. 被引量:3
  • 3陈东,张鹏,刘国辉.人工骨生物材料的研究进展[J].临床骨科杂志,2007,10(4):366-369. 被引量:10
  • 4BODEN S D, KANG J, SANDHU H, et al. Use of recombinant human bone morphogenetic protein-2 to achieve posterolateral lumb ized clinical [J]. Spine, n humans: a prospective, randompilot trial, 2002 Volvo Award in clinical studies 2002, 7(23) ,2662-2673.
  • 5GOVENDER S, CSIMMA C, GENANT H K, et al. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures:a prospective, controlled, randomized study of four hundred and fifty patients[J]. J Bone Joint Surg Am, 2002, 84-A(12):2123-2134.
  • 6ZLOTOLOW D A, VACCARO A R, SALAMON M L, et al. The role of human bone morphogenetic proteins in spinal fusion[J].J Am Acad OrthopSurg, 2000, 8(1):8-9.
  • 7KANEKO H, ARAKAWA T, MANO H, et al. Direct stimulation of osteoclastic bone resorption by bone morphogenetic protein (BMP)-2 and expression of BMP receptors in mature osteoclasts[J].Bone, 2000, 27(4) :479-486.
  • 8AONO A, HAZAMA M, NOTOYA K, et al. Potent ectopic bone-inducing activity of bone morphogenetic protein-4/7 heterodimer[J]. Biochem Biophys Res Commun, 1995, 210(3): 670-677.
  • 9ISRAEL D I, NOVE J, KERNS K M, et al. Heterodimeric bone morphogenetic proteins show enhanced activity in vitro and in vivo[J]. Growth Factors, 1996, 13(3-4) :291-300.
  • 10ZHU W, RAWLINS B A, BOACHIE-ADJEI O, et al. Combined bone morphogenetic protein-2 and -7 gene transfer enhances osteoblastle differentiation and spine fusion in a rodent model[J]. J Bone Miner Res, 2004, 19(12):2021-2032.

引证文献6

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部